Form 4: Cardinal Health CIO Sells Shares Under 10b5-1 Plan

Cardinal Health's Chief Information Officer, Michelle D. Greene, sold 2,746 common shares for approximately $228.51 per share under a pre-arranged 10b5-1 plan.

Summary

• Michelle D. Greene, Chief Information Officer of Cardinal Health Inc. (CAH), reported the sale of common shares.
• A total of 2,746 common shares were sold in two separate transactions on February 27, 2026.
• The first transaction involved the sale of 100 shares at a price of $228.55 per share.
• The second transaction involved the sale of 2,646 shares at a price of $228.47 per share.
• The weighted average sale price for these transactions was approximately $228.51 per share.
• Following these transactions, Michelle D. Greene beneficially owns 12,230 common shares directly.
• The transactions were executed pursuant to a Rule 10b5-1(c) contract, instruction, or written plan.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. While it represents insider selling, the execution under a Rule 10b5-1 plan suggests a planned financial management decision rather than a reaction to new material information, thus mitigating potential negative sentiment.

Positives

• The sale was conducted under a Rule 10b5-1(c) plan, indicating it was pre-scheduled and not a reaction to new, undisclosed negative information about the company.

Negatives

• The sale by a Chief Information Officer reduces the direct equity stake of a key executive in the company.

Risks

• Market perception of insider selling, even if pre-planned, could lead to short-term negative sentiment among some investors.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance.

Industry Context

StockSavvy.ai notes that insider sales, particularly those executed under a Rule 10b5-1 plan, are a common practice for executives managing personal finances, diversifying portfolios, or exercising stock options, and do not necessarily signal a lack of confidence in the company's future.

Corporate Governance

Stakeholder Impact

• Shareholders: May view the reduction in insider ownership with slight caution, though the 10b5-1 plan mitigates concerns about opportunistic selling.

Key Dates

Recommendation

The sale by a Chief Information Officer, while reducing insider ownership, was executed under a pre-arranged Rule 10b5-1 plan. This suggests a planned personal financial management decision rather than a reflection of new material information about Cardinal Health's prospects, thus warranting a neutral 'hold' stance.

Keywords

Cardinal Health, CAH, Insider Trading, Form 4, Stock Sale, Michelle D. Greene, Chief Information Officer, 10b5-1 Plan